Acalabrutinib
Zanubrutinib
Obinutuzumab
Update Venetoclax in CLL
ASH: COVID-19 Resources for Managing Blood Cancers
Leukemia & Lymphoma Society
NCCN Guidelines for Patients
Patient Power